Stock-Split Watch: Could These 2 Growth Stocks Be Next?
Over the past few years, we have witnessed several high-profile stock splits. Of course, these moves don't fundamentally change the value of a corporation. However, they can generate some buzz and renewed interest from investors, and allow people on a budget to acquire whole shares of companies with less money, as opposed to opting for fractional shares.
Companies sometimes institute stock splits when their shares become "too expensive." With that in mind, let's look at two companies that could go that route based on their share prices: (NASDAQ: REGN) and Booking Holdings (NASDAQ: BKNG). The good thing is that, stock split or not, both companies look like excellent options for investors.
Regeneron became a publicly traded corporation in 1991. In that time, the company hasn't conducted a single stock split. However, with the biotech performing well, especially over the past couple of years, its stock price has become quite pricey. Regeneron's shares are changing hands for about $796 as of this writing -- that's a lot for a single share of a company.
Source Fool.com
Regeneron Pharmaceuticals Inc. Aktie
Die Regeneron Pharmaceuticals Inc. Aktie zieht viel Aufmerksamkeit auf sich: Viel mehr Buy- als Sell-Einschätzungen.
Ein Kursziel von 1085 € für Regeneron Pharmaceuticals Inc. zeigt ein leicht positives Potenzial im Vergleich zum aktuellen Kurs von 1021.0 €.
